Getty ImagesRelated
HDFC Securities has buy call on Amrutanjan Health Care with a target price of Rs 970. The current market price of Amrutanjan Health Care is Rs 912.6.
Time period given by analyst is six months when Amrutanjan Health Care Ltd. price can reach defined target.
Amrutanjan Health Care Ltd., incorporated in the year 1936, is a Small Cap company (having a market cap of Rs 2645.96 Crore) operating in Pharmaceuticals sector.
Amrutanjan Health Care Ltd. key Products/Revenue Segments include Pharmaceuticals, Sale of services, Raw Materials and Scrap for the year ending 31-Mar-2021.
Financials
For the quarter ended 30-09-2021, the company reported a Standalone Total Income of Rs 114.67 Crore, up 41.65 % from last quarter Total Income of Rs 80.95 Crore and up 19.25 % from last year same quarter Total Income of Rs 96.16 Crore. Company reported net profit after tax of Rs 19.85 Crore in latest quarter.
Investment Rationale
AHCL’s earnings grew at a CAGR 17% FY17-21. Going forward, the brokerage is positive on the future growth prospects and expect AHCL to be ahead of the category performance mainly in the OTC segment. AHCL’s revenue and PAT is likely to record a growth of 17.5% and 16.7% CAGR over FY21-23E. Along with this it expects the company to generate consistent FCF with consistent high ROEs. The Comfy brand is expected to be the key growth driver for AHCL. It expects, “Comfy” revenues to grow at CAGR 28% while other OTC products are expected to grow at CAGR 13.2% over FY21-23E. Though AHCL is in branded personal are segment, it may not get the valuations that other FMCG players get due to its single brand and single segment concentration, though it has been working to diversify that and has succeeded to some extent so far. However it feels that there is a scope for some upward valuation re-rating in the stock currently.
Promoter/FII Holdings
Promoters held 50.02 per cent stake in the company as of 30-Sep-2021, while FIIs owned 1.53 per cent, DIIs 6.94 per cent.
Time period given by analyst is six months when Amrutanjan Health Care Ltd. price can reach defined target.
Amrutanjan Health Care Ltd., incorporated in the year 1936, is a Small Cap company (having a market cap of Rs 2645.96 Crore) operating in Pharmaceuticals sector.
Amrutanjan Health Care Ltd. key Products/Revenue Segments include Pharmaceuticals, Sale of services, Raw Materials and Scrap for the year ending 31-Mar-2021.
Financials
For the quarter ended 30-09-2021, the company reported a Standalone Total Income of Rs 114.67 Crore, up 41.65 % from last quarter Total Income of Rs 80.95 Crore and up 19.25 % from last year same quarter Total Income of Rs 96.16 Crore. Company reported net profit after tax of Rs 19.85 Crore in latest quarter.
Investment Rationale
AHCL’s earnings grew at a CAGR 17% FY17-21. Going forward, the brokerage is positive on the future growth prospects and expect AHCL to be ahead of the category performance mainly in the OTC segment. AHCL’s revenue and PAT is likely to record a growth of 17.5% and 16.7% CAGR over FY21-23E. Along with this it expects the company to generate consistent FCF with consistent high ROEs. The Comfy brand is expected to be the key growth driver for AHCL. It expects, “Comfy” revenues to grow at CAGR 28% while other OTC products are expected to grow at CAGR 13.2% over FY21-23E. Though AHCL is in branded personal are segment, it may not get the valuations that other FMCG players get due to its single brand and single segment concentration, though it has been working to diversify that and has succeeded to some extent so far. However it feels that there is a scope for some upward valuation re-rating in the stock currently.
Promoter/FII Holdings
Promoters held 50.02 per cent stake in the company as of 30-Sep-2021, while FIIs owned 1.53 per cent, DIIs 6.94 per cent.
(Disclaimer: Recommendations given in this section or any reports attached herein are authored by an external party. Views expressed are that of the respective authors/entities. These do not represent the views of Economic Times (ET). ET does not guarantee, vouch for, endorse any of its contents and hereby disclaims all warranties, express or implied, relating to the same. Please consult your financial adviser and seek independent advice.
(What's moving Sensex and Nifty Track latest market news, stock tips and expert advice, on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds .)
...moreDownload The Economic Times News App to get Daily Market Updates & Live Business News.
Subscribe to The Economic Times Prime and read the Economic Times ePaper Online.and Sensex Today.
Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price
Read More News on
(What's moving Sensex and Nifty Track latest market news, stock tips and expert advice, on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds .)
...moreDownload The Economic Times News App to get Daily Market Updates & Live Business News.
Subscribe to The Economic Times Prime and read the Economic Times ePaper Online.and Sensex Today.
Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price
Pick the best stocks for yourself
Powered by
Get Unlimited Access to The Economic Times
